Quantcast

Latest Medicinal chemistry Stories

2014-07-18 23:01:23

US authorities are holding imports more than ever before, particularly at ports that have a history of holding products, and imports from India. Attend this invaluable webinar and find out how to be in the “Safe Zone” when it comes to dealing with the FDA and Customs. Falls Church, VA (PRWEB) July 18, 2014 Improving Your FDA Import Success Rate: Tips for Thinking Ahead of the FDA **FDAnews Webinar** Aug. 7, 2014 — 1:30 p.m. – 3:00 p.m. EDT...

2014-07-17 08:29:54

ORLANDO, Fla., July 17, 2014 /PRNewswire/ -- Mevesi Inc., the leading data automation service for pharmacies in the United States announces their integration with ProviderPay. This integration provides customer pharmacies insight into health care claim data and reconciliation results enabling pharmacies the ability to track and maximize their reimbursements, as well as better managing and forecasting their cash flow. Cash Management Solution provides you with real time Health Care...

2014-07-16 23:10:51

Dr. Ginette Collazo, a 15 year veteran of helping drug, biologic and device firms reduce manufacturing errors by 50 percent or more, will conduct a one-of-a-kind workshop that teaches quality managers and manufacturing excellence professionals how to reduce errors and improve quality metrics. Based on her ground-breaking research, Dr. Collazo explains how small improvements in both manufacturing systems and improved employee training can deliver big results. Falls Church, VA (PRWEB) July...

2014-07-15 23:11:01

On July 11, the FDA alerted healthcare professionals not to use drugs marketed as sterile produced by Unique Pharmaceuticals Ltd. as they may be contaminated. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. San Diego, CA (PRWEB) July 15, 2014 AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on Sterile Drug Products. The FDA notified...

2014-07-15 20:21:29

SAN DIEGO & MONROVIA, Calif., July 15, 2014 /PRNewswire/ -- Shareholder rights law firm Robbins Arroyo LLP announces that an investor of STAAR Surgical Company (NYSE: STAA) has filed a federal securities fraud class action complaint in the U.S. District Court for the Central District of California. The complaint alleges that the company and certain of its officers and directors violated the Securities Exchange Act of 1934 between February 27, 2013 and June 30, 2014 (the "Class...

2014-07-15 08:28:36

EXTON, Pa., July 15, 2014 /PRNewswire/ -- Absorption Systems, a leader in novel test systems for drug transporters, announces a license agreement with Pfizer Inc., in which Pfizer will in-license Absorption Systems' BCRP-MDCK cells. This cell line is stably transfected with the human ABCG2 gene, which codes for a protein known as BCRP (breast cancer resistance protein). This proprietary human BCRP assay system is designed to enable the testing of new drug candidates for interactions...

2014-07-14 12:27:06

Researchers to Use IBM Blue Gene/Q Supercomputer for Computational Drug Design and Discovery RESEARCH TRIANGLE PARK, N.C., July 14, 2014 /PRNewswire/ -- Cloud Pharmaceuticals, Inc., a therapeutics company focused on cloud-based drug design and development, announced today the expansion of its drug design and development program. The company has been granted supercomputing time at Argonne National Laboratory to design inhibitors of multiple parasitic targets. Through a...

2014-07-14 12:26:55

Majority of Contract Pharmacies Located Outside of Underserved Neighborhoods WASHINGTON, July 14, 2014 /PRNewswire-USNewswire/ -- A new white paper released today by the Alliance for Integrity and Reform of 340B (AIR 340B) suggests that rapid contract pharmacy growth in the 340B program may not directly benefit the vulnerable patients for whom the program is intended. The paper, "The Impact of Growth in 340B Contract Pharmacy Arrangements," highlights the growth of thousands of...

2014-07-12 23:04:22

On June 19, the FDA added Gold Vigra and Miraculous Evil Root to its previous notification not to use specific male sexual enhancement products due to undeclared drug ingredients. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. San Diego, CA (PRWEB) July 11, 2014 AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on Male Sexual...

2014-07-11 16:23:25

FALLS CHURCH, Va., July 11, 2014 /PRNewswire/ -- Poor bioavailability is a major reason for compounds to fail in preclinical development. Technology Catalysts International (TCI), a leading global pharmaceutical consulting firm, has compiled and analyzed technical and market information pertaining to the delivery of poorly water soluble or poorly permeable pharmaceutical compounds. Due to the complex nature of a multitude of existing as well as newly-discovered active ingredients,...


Latest Medicinal chemistry Reference Libraries

European Journal of Medical Chemistry
2012-05-12 22:03:06

The European Journal of Medical Chemistry is a peer-reviewed scientific journal for medical chemistry. It is published by Elsevier. It was established in 1966 under the title Chimica Therapeutica. That name was maintained until 1973. Even after changing to its current name in 1974, the journal was still subtitled Chimica Therapeutica until 1981; from 1982 to 1986 it was subtitled Chimie Therapeutique, indicating its French origin. The Journal publishes studies on all aspects of medicinal...

More Articles (1 articles) »
Word of the Day
humgruffin
  • A terrible or repulsive person.
Regarding the etymology of 'humgruffin,' the OED says (rather unhelpfully) that it's a 'made-up word.' We might guess that 'hum' comes from 'humbug' or possibly 'hum' meaning 'a disagreeable smell,' while 'gruffin' could be a combination of 'gruff' and 'griffin.'